Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Oct;18(10):1073.
doi: 10.1111/jch.12832. Epub 2016 Apr 21.

Canagliflozin and Hypertension: Is It the Optimal Choice for All Hypertensive Patients?

Affiliations
Comment

Canagliflozin and Hypertension: Is It the Optimal Choice for All Hypertensive Patients?

Konstantinos Stavropoulos et al. J Clin Hypertens (Greenwich). 2016 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors report no specific funding in relation to this research and no conflicts of interest to disclose.

Comment in

  • Response to Stavropoulos.
    Townsend RR, Machin I, Ren J, Trujillo A, Kawaguchi M, Vijapurkar U, Damaraju CV, Pfeifer M. Townsend RR, et al. J Clin Hypertens (Greenwich). 2016 Oct;18(10):1074-1075. doi: 10.1111/jch.12831. Epub 2016 Apr 21. J Clin Hypertens (Greenwich). 2016. PMID: 27098365 Free PMC article. No abstract available.

Comment on

References

    1. Townsend RR, Machin I, Ren J, et al. Reductions in mean 24‐hour ambulatory blood pressure after 6‐week treatment with canagliflozin in patients with type 2 diabetes mellitus and hypertension. J Clin Hypertens (Greenwich). 2016;18:43–52. - PMC - PubMed
    1. Imprialos KP, Sarafidis PA, Karagiannis AI. Sodium‐glucose cotransporter‐2 inhibitors and blood pressure decrease: a valuable effect of a novel antidiabetic class? J Hypertens. 2015;33:2185–2197. - PubMed
    1. Mancia G, Parati G. Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta‐analysis. J Hypertens. 2004;22:435–445. - PubMed
    1. Flack JM, Sica DA, Bakris G, et al. Management of high blood pressure in blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension. 2010;56:780–800. - PubMed
    1. Weber MA, Jamerson K, Bakris GL, et al. Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial. Lancet. 2013;381:537–545. - PubMed

LinkOut - more resources